These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
357 related articles for article (PubMed ID: 17220691)
1. The cost-effectiveness of two strategies for vaccinating US veterans with hepatitis C virus infection against hepatitis A and hepatitis B viruses. Jakiche R; Borrego ME; Raisch DW; Gupchup GV; Pai MA; Jakiche A Am J Med Sci; 2007 Jan; 333(1):26-34. PubMed ID: 17220691 [TBL] [Abstract][Full Text] [Related]
2. Comparison of two vaccination strategies against hepatitis A and B in patients with chronic hepatitis C. Díez Redondo MP; Almaraz A; Jiménez Rodríguez-Vila M; Santamaría A; de Castro J; Torrego JC; Caro-Patón A Rev Esp Enferm Dig; 2009 Apr; 101(4):265-74. PubMed ID: 19492902 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of hepatitis A virus and hepatitis B virus immunity in patients with polymerase chain reaction-confirmed hepatitis C: implications for vaccination strategy. Siddiqui F; Mutchnick M; Kinzie J; Peleman R; Naylor P; Ehrinpreis M Am J Gastroenterol; 2001 Mar; 96(3):858-63. PubMed ID: 11280565 [TBL] [Abstract][Full Text] [Related]
4. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases. Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833 [TBL] [Abstract][Full Text] [Related]
5. Prevalence of hepatitis B and A virus markers and vaccination indication in cirrhotic patients evaluated for liver transplantation in Spain. Gutiérrez Domingo I; Pascasio Acevedo JM; Alcalde Vargas A; Ramos Cuadra A; Ferrer Ríos MT; Sousa Martín JM; Sayago Mota M; Giráldez Gallego A; Suárez Artacho G Transplant Proc; 2012; 44(6):1502-4. PubMed ID: 22841196 [TBL] [Abstract][Full Text] [Related]
6. The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C. Myers RP; Gregor JC; Marotta PJ Hepatology; 2000 Apr; 31(4):834-9. PubMed ID: 10733536 [TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C. Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195 [TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of screening and vaccinating Asian and Pacific Islander adults for hepatitis B. Hutton DW; Tan D; So SK; Brandeau ML Ann Intern Med; 2007 Oct; 147(7):460-9. PubMed ID: 17909207 [TBL] [Abstract][Full Text] [Related]
9. Meeting vaccination quality measures for hepatitis A and B virus in patients with chronic hepatitis C infection. Kramer JR; Hachem CY; Kanwal F; Mei M; El-Serag HB Hepatology; 2011 Jan; 53(1):42-52. PubMed ID: 21254161 [TBL] [Abstract][Full Text] [Related]
10. Health economic assessment of universal immunization of toddlers against Hepatitis A Virus (HAV) in Mexico. Carlos F; Gómez JA; Anaya P; Romano-Mazzotti L Hum Vaccin Immunother; 2016; 12(1):52-63. PubMed ID: 26503702 [TBL] [Abstract][Full Text] [Related]
11. Screening for hepatitis A and B antibodies in patients with chronic liver disease. Lau DT; Hewlett AT Am J Med; 2005 Oct; 118 Suppl 10A():28S-33S. PubMed ID: 16271538 [TBL] [Abstract][Full Text] [Related]
12. Hepatitis A and B screening and vaccination rates among patients with chronic liver disease. Ramirez JC; Ackerman K; Strain SC; Ahmed ST; de Los Santos MJ; Sears D Hum Vaccin Immunother; 2016; 12(1):64-9. PubMed ID: 26836326 [TBL] [Abstract][Full Text] [Related]
13. Low rates of hepatitis A and B vaccination in patients with chronic hepatitis C at an urban methadone maintenance program. Felsen UR; Fishbein DA; Litwin AH J Addict Dis; 2010 Oct; 29(4):461-5. PubMed ID: 20924882 [TBL] [Abstract][Full Text] [Related]
14. A reappraisal of hepatitis B virus vaccination strategies using cost-effectiveness analysis. Bloom BS; Hillman AL; Fendrick AM; Schwartz JS Ann Intern Med; 1993 Feb; 118(4):298-306. PubMed ID: 8420448 [TBL] [Abstract][Full Text] [Related]
15. Should Brazilian patients with chronic hepatitis C virus infection be vaccinated against hepatitis A virus? Villar LM; de Melo MM; Calado IA; de Almeida AJ; Lampe E; Gaspar AM J Gastroenterol Hepatol; 2009 Feb; 24(2):238-42. PubMed ID: 19215334 [TBL] [Abstract][Full Text] [Related]
16. Strategies for the prevention of perinatal hepatitis B transmission in a marginalized population on the Thailand-Myanmar border: a cost-effectiveness analysis. Devine A; Harvey R; Min AM; Gilder MET; Paw MK; Kang J; Watts I; Hanboonkunupakarn B; Nosten F; McGready R BMC Infect Dis; 2017 Aug; 17(1):552. PubMed ID: 28793866 [TBL] [Abstract][Full Text] [Related]
17. Risks associated with hepatitis A and hepatitis B in patients with hepatitis C. Koff RS J Clin Gastroenterol; 2001 Jul; 33(1):20-6. PubMed ID: 11418785 [TBL] [Abstract][Full Text] [Related]
18. Vaccine induced Hepatitis A and B protection in children at risk for cystic fibrosis associated liver disease. Shapiro AJ; Esther CR; Leigh MW; Dellon EP Vaccine; 2013 Jan; 31(6):906-11. PubMed ID: 23261047 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of High-Dose, Rapid, Hepatitis A and B Vaccination Schedules in Patients With Cirrhosis. Wigg AJ; Wundke R; McCormick R; Muller KR; Ramachandran J; Narayana SK; Woodman RJ Clin Gastroenterol Hepatol; 2019 May; 17(6):1210-1212.e1. PubMed ID: 30144521 [TBL] [Abstract][Full Text] [Related]
20. Cost-effective analysis of hepatitis A prevention in Ireland. Rajan E; Shattock AG; Fielding JF Am J Gastroenterol; 2000 Jan; 95(1):223-6. PubMed ID: 10638588 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]